# Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy

> **NCT06782217** · — · RECRUITING · sponsor: **Inmunotek S.L.** · enrollment: 120 (estimated)

## Conditions studied

- Allergy, Insect Venom
- Allergy Insect Stinging
- Insect Sting Allergy

## Interventions

- **BIOLOGICAL:** VENOX

## Key facts

- **NCT ID:** NCT06782217
- **Lead sponsor:** Inmunotek S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2026-11-01
- **Final completion:** 2027-02-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06782217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06782217, "Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06782217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*